Skip to main content
Toggle navigation
FR
EN
Drupal
Main navigation EN
About Crossject
Who we are
Governance
R&D
Our technology
ZENEO®: needle-free technology
Products under development
Our supply chain
Therapeutic areas
Epileptic seizure
Acute adrenal crisis
Anaphylactic shock
Severe asthma crisis
Migraines and cluster headaches
Opioid overdose
Rheumatoid arthritis
Main navigation 2 EN
Finances
Profile
Analyst coverage
Financial releases
News
Our news
Press releases
Careers
Working at Crossject
Contact
Search
Search
Enter the terms you wish to search for.
Home
Finances
Crossject announces the principle of the free issue and allotment of warrants to the shareholders and new € 2.5 million convertible bond
Crossject announces the principle of the free issue and allotment of warrants to the shareholders and new € 2.5 million convertible bond
Image
Date de parution
2018/07/23
PDF du document
2018_07_ CP CP BSA_OC ENG.pdf
781.55 KB